PE-backed AskBio buys Synpromics
AskBio, backed by private equity firms TPG Capital and Vida Ventures, has bolted on gene therapy developer Synpromics.
More on Portfolio management
Ergon et al. sell Indo to PE-backed Rodenstock
Sherpa Capital and Oquendo Capital are also selling their stakes in the ophthalmic lenses producer
Phoenix sells 1000Heads to PE-backed Labelium
Main sells Obi4wan to PE-backed Spotler
Exit to CNBB portfolio company Spotler Group ends a holding period of almost six years
The Bolt-Ons Digest – 19 April 2022
Triton's All4Labels; Committed's MR Marine; Goldman Sach's Advania; Main Capital's Perbility; and more
Latest News
Gyrus buys majority stake in Katalist Group
GP and Katalist's founders are planning bolt-ons for the food and pharma supply chain software firm
Bain Capital, Nextalia to acquire Deltatre from Bruin Sports Capital
Italian sports technology provider first sale attempt was hampered by the onset of COVID-19 in early 2020
FirstAvenue appoints Chronias as capital solutions group head
Nick Chronias will lead the firm’s focus on private credit and private infrastructure secondaries
Riverside appoints Höppner as chief sustainability officer
Dörte Höppner joined the GP in 2017 and will be responsible for its ESG initiatives globally